Trial HoldingsTSE:141A -1.94%9 EBITDA Margin % is 9.05% as of Dec. 2025, which is 136% above its 10-year median of 3.83. GuruFocus rates TSE:141A with a GF Score™ of 9/100. The stock has 5 warning signs investors should review. Among 310 Retail - Defensive companies, Trial Holdings ranks worse than 56.13% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Trial Holdings's EBITDA for the
three
months ended in Dec. 2025 was 円31,455 Mil. Trial Holdings's Revenue for the
three
months ended in Dec. 2025 was 円347,500 Mil. Therefore, Trial Holdings's EBITDA margin for the quarter that ended in Dec. 2025 was 9.05%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Trial Holdings EBITDA Margin % Related Terms
Trial Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Trial Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:141A vs WMT, COST, TGT: EBITDA Margin % Comparison
For the Discount Stores subindustry, Trial Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trial Holdings EBITDA Margin % vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, Trial Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Trial Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trial Holdings (TSE:141A) has a EBITDA Margin % of 9.05% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Trial Holdings and its competitors. This is 136% above median its historical median of 3.83. Over the past decade, Trial Holdings' EBITDA Margin % has ranged from 3.44 to 5.10. According to the industry distribution chart, Trial Holdings ranks #174 out of 310 companies in the Retail - Defensive industry, placing it in the top 56.1%.
Is Trial Holdings' EBITDA Margin % too high?
Trial Holdings' current EBITDA Margin % of 9.05% is 136% above median its 10-year median of 3.83. Over the past 10 years, this metric has ranged from a low of 3.44 to a high of 5.10. The Retail - Defensive industry median EBITDA Margin % is 6.01. Trial Holdings' value of 9.05% is 50.6% above this industry median. Based on the distribution chart, Trial Holdings ranks #174 out of 310 companies in the Retail - Defensive industry, which is below the industry midpoint. Overall, Trial Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Trial Holdings' EBITDA Margin % compare to WMT and COST?
According to the Retail - Defensive industry distribution chart, Trial Holdings ranks #174 out of 310 companies for EBITDA Margin %. This places Trial Holdings in the lower half of its industry. The industry median EBITDA Margin % is 6.01. Trial Holdings' value of 9.05% is 50.6% above this benchmark. Historically, Trial Holdings' own EBITDA Margin % has ranged from 3.44 to 5.10 over the past decade. While the company's 10-year median is 3.83 vs. the industry median of 6.01, Trial Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Retail - Defensive company?
The median EBITDA Margin % among Retail - Defensive companies is 6.01, based on 310 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trial Holdings's current EBITDA Margin % of 9.05% is 50.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Trial Holdings and its competitors. For the Retail - Defensive industry, the median EBITDA Margin % is 6.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trial Holdings's current EBITDA Margin % is 9.05%, which is 136% above median its own 10-year median of 3.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trial Holdings stock overvalued right now?
Trial Holdings (TSE:141A) has a current EBITDA Margin % of 9.05%. The current EBITDA Margin % is 9.05%, which is 136% above median its 10-year median of 3.83 and 50.6% above the Retail - Defensive industry median of 6.01. Trial Holdings' overall GF Score™ is 9/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Trial Holdings (TSE:141A), the current EBITDA Margin % is 9.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trial Holdings Inc is a holding company. Along with its subsidiaries, it operates in the following reportable segments: Retail Distribution Business and Retail AI Business. The majority of its revenue is generated from the Retail Distribution Business, which operates discount stores across Japan, ranging from small to large, along with medium-sized supercenters. The product lineup of the stores focuses on food (especially fresh foods), and non-food items include daily necessities and hard goods. The Retail AI Business segment is mainly involved in research and development aimed at transforming stores into smart stores, as well as the sale of products and the outsourcing of services related to smart stores. In addition, the group is involved in real estate and resort-related businesses.
9GF Score
Get the complete analysis for TSE:141A
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:141A has been successfully added to your 
